Broad-spectrum β-lactams in obese non-critically ill patients. - Wikidata - awgldk - TriplyDB

Broad-spectrum β-lactams in obese non-critically ill patients.

Broad-spectrum β-lactams in obese non-critically ill patients.

http://www.wikidata.org/entity/Q33839225

about

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery.Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.Comprehensive Guidance for Antibiotic Dosing in Obese Adults.What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial in Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing.

P2860

Q35124710-B551D896-520E-42DA-83E0-9EB7E7A5878B Q36076101-8223BD39-A51C-4FE2-97BA-D5EA5904D1E3 Q37538609-C818C1C8-5B58-4BC0-8CB0-D528CA3380BE Q39484436-B2AFA755-8CE2-44EE-B48D-7B9B5816B2C2 Q40067964-1F0F85E7-8307-4633-BB8A-4D264A24DA50 Q40172540-87CDA882-2447-4382-88E8-D3DEFC05AD02 Q41349399-949BFAA8-DF8D-4DBE-BF2A-B865C2A4F067 Q42228348-157ACDB6-406F-44B2-B721-2BF2CAB50434

P2860

Broad-spectrum β-lactams in obese non-critically ill patients.

http://www.wikidata.org/entity/Q33839225

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Broad-spectrum β-lactams in obese non-critically ill patients.

@ast

Broad-spectrum β-lactams in obese non-critically ill patients.

@en

type

label

Broad-spectrum β-lactams in obese non-critically ill patients.

@ast

Broad-spectrum β-lactams in obese non-critically ill patients.

@en

prefLabel

Broad-spectrum β-lactams in obese non-critically ill patients.

@ast

Broad-spectrum β-lactams in obese non-critically ill patients.

@en

P1433

Q33839225-18A212EB-73F9-4A36-B07A-10425706703A

P1476

Q33839225-252B2496-CD90-4059-A08D-772FDA8D364B

P2093

Q33839225-1FEA24BD-A06B-4C26-AE6C-295C9449DF7E

Q33839225-2E8F9FF5-94BD-444D-B728-08F059D47442

Q33839225-4BF67D68-DF83-4BFB-821F-278639A3FB27

Q33839225-54C07712-A800-492E-9E0B-4B5B0057883A

Q33839225-87FFD2F9-6A8A-4CB1-86DD-D9D8D6664D84

Q33839225-D14E716A-CEB0-4514-92C3-E70E6E9F6213

Q33839225-EF50E342-2EDD-46EA-BD43-7CA4D20B6178

Q33839225-F60AF727-0003-4E55-A6D1-FCC26AC1097B

P2860

Q33839225-00AB80EE-0C52-4C52-BA2B-699FD6D28899

Q33839225-03D30A62-4ED5-4016-BE9C-52FE9101AECE

Q33839225-06D30DDD-0A47-4EDD-8FCD-F0DDEEEA432D

Q33839225-227FC629-3E81-4F21-A381-E6B279BD0950

Q33839225-279EAC0E-F68F-4B7F-8AA9-B7D3821B1783

Q33839225-2B9FFF4B-E299-48CF-89F7-F43B9248C3F7

Q33839225-318B1911-18C7-4DDE-93C2-7EF9DEA168DF

Q33839225-3CA8DD0D-D6FA-439A-A0B2-9164A71CEB72

Q33839225-4111A6C7-DC33-40B1-A932-EC6FEEC99086

Q33839225-4A75DCD8-1285-4D0B-8A0D-AF1043093A6F

P2888

Q33839225-CE6198BE-9B59-48E4-8C86-B514D5A9CDCB

P304

Q33839225-9C788EF1-0044-44D0-A260-6EE0635352C4

P31

Q33839225-C9693EAF-6549-48D9-98EB-0CC112D1BD6D

P356

Q33839225-85D9F222-FB50-4C61-A415-CDF2F38D7F66

P478

Q33839225-59850E7B-C889-45B7-A12D-45309425B25C

P577

Q33839225-4BD2BB1B-77C6-48C3-9A94-BD9976E19B59

P5875

Q33839225-AD47AAD1-D77E-4ECE-ACEB-52FACEAF8977

P6179

Q33839225-F8B9E752-BBAA-45F8-9A07-085A1B09C59F

P698

Q33839225-2F79A511-CE17-4F53-AEC3-A7F32D3C09DF

P921

Q33839225-D7D074F7-26F4-400C-98C2-DA79D220753D

P932

Q33839225-DD14E8F4-DDB8-49A9-B34D-89402705CF5B

P356

P1433

Nutrition & Diabetes

P1476

Broad-spectrum β-lactams in obese non-critically ill patients.

@en

P2093

E Maillart

http://www.w3.org/2001/XMLSchema#string

F Cotton

http://www.w3.org/2001/XMLSchema#string

F Jacobs

http://www.w3.org/2001/XMLSchema#string

F S Taccone

http://www.w3.org/2001/XMLSchema#string

F Wolff

http://www.w3.org/2001/XMLSchema#string

M Beumier

http://www.w3.org/2001/XMLSchema#string

M Hites

http://www.w3.org/2001/XMLSchema#string

R Surin

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of creatinine clearance from serum creatinine

Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa.

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection model

Vancomycin pharmacokinetics in normal and morbidly obese subjects

Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.

What is the best size descriptor to use for pharmacokinetic studies in the obese?

Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.

Case-control study of drug monitoring of β-lactams in obese critically ill patients.

Obesity and renal hemodynamics.

P2888

P304

e119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NUTD.2014.15

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263321468

http://www.w3.org/2001/XMLSchema#string

P6179

1039760898

http://www.w3.org/2001/XMLSchema#string

P698

24956136

http://www.w3.org/2001/XMLSchema#string

P921

P932

4079925

http://www.w3.org/2001/XMLSchema#string